Login / Signup

Alcohol use disorder severity moderates clinical response to varenicline.

Suzanna DonatoReJoyce GreenLara A Ray
Published in: Alcoholism, clinical and experimental research (2021)
Treatment response to varenicline may be greater among individuals with less-severe AUD, as evidenced by both reductions in drinking outcomes and improvements in psychosocial functioning.
Keyphrases
  • alcohol use disorder
  • smoking cessation
  • replacement therapy
  • mental health
  • early onset
  • type diabetes
  • combination therapy
  • alcohol consumption
  • glycemic control
  • weight loss